Johnson & Johnson Innovation will host a virtual partnering event to actively engage with the German & DACH life sciences ecosystem and highlight how we interact with entrepreneurs, universities, startups and other innovators.
This will be relevant for innovators across all our therapeutic areas (Oncology, Immunology, Infectious Diseases & Vaccines, Cardio Vascular/Metabolic, Neuroscience), as well as for Medical Devices and Consumer Healthcare.
Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, our Johnson & Johnson Innovation team is looking to present its external collaboration model and meet life sciences start-ups across Europe through virtual events and 1:1 sessions.
The event will include an open briefing on the Johnson & Johnson Innovation model on November 17, followed by one-to-one partnering meetings with selected companies on November 17-18.
Apply to get the opportunity for a 1:1 meetings with the J&J Innovation cross-sectoral team by submitting a request before 20th of October. The full details of the event can be found here.
